28498618Obara W, Sato F, Takeda K, Kato R, Kato Y, Kanehira M, Takata R, Mimata H, Sugai T, Nakamura Y, Fujioka TCancer scienceCancer Vaccines; Cell Cycle Proteins; Prostatic Neoplasms, Castration-ResistantAged; Aged, 80 and over; Enzyme-Linked Immunospot Assay; HLA-A24 Antigen; Humans; Male; Middle Aged; T-Lymphocytes, Cytotoxic; Vaccines, SubunitPhase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer. Cancer Sci. 2017 Jul; 108(7):1452-1457.Cancer Sci2017-06-23T00:00:002017Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461294Aged, 80 and overD000368Living Beings1341183530.294764AgedAuthorship 104058100.1564480.1564481authors10.2512has subject areaD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD006801Living Beings2262862810.130052HumansD008297Physiology1931408600.201617MaleD019496Chemicals & Drugs461560.877607Cancer VaccinesD018797Chemicals & Drugs1733880.801321Cell Cycle ProteinsD013602Anatomy783140.879073T-Lymphocytes, CytotoxicD022223Chemicals & Drugs25550.969928Vaccines, SubunitD064129Disorders291050.871479Prostatic Neoplasms, Castration-ResistantD058501Procedures670.997329Enzyme-Linked Immunospot AssayD059871Chemicals & Drugs7200.988256HLA-A24 AntigenMedicineUniversity of ChicagoYusukeNakamuraYusuke Nakamura41.78927490000000-87.60125000000000582Nakamura, YusukeEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professor